Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2013 | 08-2013 | 06-2013 | 05-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,160 | 1,160 | 830 | 830 | 1,190 |
| Marketable Securities | 2,660 | 2,660 | 2,940 | 2,940 | 3,590 |
| Receivables | 790 | 790 | 1,010 | 1,010 | 830 |
| Inventories | 60 | 60 | 210 | 210 | 220 |
| Other current assets | 200 | 200 | 60 | 60 | 40 |
| TOTAL | $4,870 | $4,870 | $5,050 | $5,050 | $5,870 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 20,040 | 20,040 | 6,020 | 6,020 | 6,300 |
| TOTAL | $20,040 | $20,040 | $6,020 | $6,020 | $6,300 |
| Total Assets | $24,940 | $24,940 | $11,090 | $11,090 | $12,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,300 | 1,300 | 620 | 620 | 700 |
| Other current liabilities | 2,440 | 2,440 | 2,310 | 2,310 | 1,740 |
| TOTAL | $3,740 | $3,740 | $2,940 | $2,940 | $2,450 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $0 | $N/A | $0 | $N/A |
| Total Liabilities | $3,740 | $3,740 | $2,940 | $2,940 | $2,450 |
| Shareholders' Equity | |||||
| Common Shares | 43,450 | 43,450 | 28,350 | 28,350 | 28,970 |
| Retained earnings | -24,340 | -24,340 | -21,560 | -21,560 | -20,080 |
| Other shareholders' equity | 390 | 390 | 400 | 400 | 420 |
| TOTAL | $21,190 | $21,190 | $8,150 | $8,150 | $9,740 |
| Total Liabilities And Equity | $24,930 | $24,930 | $11,090 | $11,090 | $12,190 |